Literature DB >> 1161259

Studies of tumor cell lines derived from patients with malignant melanoma.

R E Gerner, H Kitamura, G E Moore.   

Abstract

Fourteen long-term human malignant melanoma cell lines established from biopsy specimens, malignant effusions and the peripheral blood are reported. Methods of culture, heterologous transplantation studies and characterization of these cell lines are presented. Several of these cell lines have retained the ability to produce pigment over a period of years, permitting bioassays at a subcellular level. Studies of cell lines grown with and without tyrosine and some of the theoretical uses of human melanoma cell lines are presented.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1161259     DOI: 10.1159/000225003

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  5 in total

1.  Comparative studies between nude and scid mice on the growth and metastatic behavior of xenografted human tumors.

Authors:  X Xie; N Brünner; G Jensen; J Albrectsen; B Gotthardsen; J Rygaard
Journal:  Clin Exp Metastasis       Date:  1992-05       Impact factor: 5.150

2.  Biological properties of human melanoma cells in culture.

Authors:  A A Creasey; H S Smith; A J Hackett; K Fukuyama; W L Epstein; S H Madin
Journal:  In Vitro       Date:  1979-05

3.  Characterization of seven human melanoma cell lines: melanogenesis and secretion of plasminogen activators.

Authors:  E G Hoal-Van Helden; E L Wilson; E B Dowdle
Journal:  Br J Cancer       Date:  1986-08       Impact factor: 7.640

4.  Do cell lines in vitro reflect the properties of the tumours of origin? A study of lines derived from human melanoma xenografts.

Authors:  K M Tveit; A Pihl
Journal:  Br J Cancer       Date:  1981-12       Impact factor: 7.640

5.  A human melanoma cell line established from xenograft in athymic mice.

Authors:  K M Tveit; O Fodstad; J V Johannessen; S Olsnes
Journal:  Br J Cancer       Date:  1980-05       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.